AAX Biotech pitching at KI Innovations InvestorDay 2026

On April 21, our CEO/CSO & Co-Founder, Daniel X. Johansson, took the stage at KI Innovations InvestorDay 2026 - and what an energizing day it was.

The event gathered some of Sweden's most exciting biotech startups alongside the investors shaping the future of the field. Pitching in that room, in front of such an experienced jury, was an invaluable opportunity to showcase how AAX Biotech is advancing the next generation of antibody-based therapies.

Beyond the pitch, it was a chance to step back from the day-to-day lab work, connect with the biotech community, and gain sharp, objective feedback on our trajectory. 

We want to extend a huge thank you to Karolinska Institutet Innovation for putting together such a thoughtful and well-curated event. We are grateful to be part of this ecosystem and are already looking forward to what comes next!  

AAX Biotech CEO/CSO & Co-Founder Daniel X. Johansson pitching at KI Innovations InvestorDay 2026.